Literature DB >> 14718482

The APOE gene and differences in life expectancy in Europe.

Douglas C Ewbank1.   

Abstract

Common alleles of the apolipoprotein-E gene (APOE) are associated with different risks of ischemic heart disease, Alzheimer's disease, and other chronic conditions in European populations. Also, the APOE allele frequencies vary widely among European countries. We estimated the proportion of differences in mortality and differences in life span that are attributable to differences in APOE allele frequencies in Europe. Mortality rates by age, sex, and APOE genotype for six countries (Denmark, Finland, France, Italy, the Netherlands, and Sweden) were used to standardize mortality rates to the allele frequencies in Italy. Differences in APOE allele frequencies explain 12%-17% of the variation among these countries in mortality in people older than 65 years and 1%-2% of the variation in life span in those older than 65 years. Differences by genotype in mortality in people older than 15 years account for about 3.5% of the genetic contribution to the variation in life span in Denmark.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718482     DOI: 10.1093/gerona/59.1.b16

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  36 in total

1.  Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.

Authors:  Maria G Matera; Daniele Sancarlo; Francesco Panza; Carolina Gravina; Grazia D'Onofrio; Vincenza Frisardi; Grazia Longo; Luigi P D'Ambrosio; Filomena Addante; Massimiliano Copetti; Vincenzo Solfrizzi; Davide Seripa; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-04-20

Review 2.  Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Authors:  Suman Lal; Srinivasa Rao Jada; Xiaoqiang Xiang; Wan-Teck Lim; Edmund J D Lee; Balram Chowbay
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations.

Authors:  Peng Hu; Yuan Han Qin; Cheng Xue Jing; Ling Lu; Bo Hu; Peng Fei Du
Journal:  Mol Biol Rep       Date:  2010-03-31       Impact factor: 2.316

4.  Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.

Authors:  May A Beydoun; Hind A Beydoun; Jay S Kaufman; Yang An; Susan M Resnick; Richard O'Brien; Luigi Ferrucci; Alan B Zonderman
Journal:  J Am Geriatr Soc       Date:  2013-03-21       Impact factor: 5.562

5.  Apolipoprotein E (APOE) and warfarin dosing in an Italian population.

Authors:  Hugo Kohnke; Maria Gabriella Scordo; Vittorio Pengo; Roberto Padrini; Mia Wadelius
Journal:  Eur J Clin Pharmacol       Date:  2005-08-26       Impact factor: 2.953

6.  Warfarin dose related to apolipoprotein E (APOE) genotype.

Authors:  Hugo Kohnke; Kristina Sörlin; Göran Granath; Mia Wadelius
Journal:  Eur J Clin Pharmacol       Date:  2005-06-11       Impact factor: 2.953

7.  Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age.

Authors:  Erik J Giltay; Aulikki Nissinen; Simona Giampaoli; Daan Kromhout
Journal:  Dement Geriatr Cogn Disord       Date:  2009-11-10       Impact factor: 2.959

8.  Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E.

Authors:  Fotios Drenos; Thomas B L Kirkwood
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

9.  Apolipoprotein E and measured physical and pulmonary function in older Taiwanese adults.

Authors:  Sarinnapha Vasunilashorn; Dana A Glei; Yu-Hsuan Lin; Noreen Goldman
Journal:  Biodemography Soc Biol       Date:  2013

10.  APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.

Authors:  H A D Keage; F E Matthews; A Yip; L Gao; C McCracken; I G McKeith; D C Rubinsztein; C Brayne
Journal:  Age Ageing       Date:  2009-11-24       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.